Our results demonstrate a statistically significant increase in HDAC1 and decrease in HDAC4, HDAC5 and HDAC6 levels in cortex and striatum of R6/2 transgenic HD mice at both early and terminal disease stages. The gene discussed is HDAC4; the disease is Huntington disease.